We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21.9B
AUM Growth
+$870M
Cap. Flow
-$433M
Cap. Flow %
-1.98%
Top 10 Hldgs %
43.67%
Holding
276
New
31
Increased
44
Reduced
103
Closed
5

Top Sells

Rank Stock Value
1
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$43.3M
2
TGT icon
Target
TGT
+$39.5M
3
XOM icon
ExxonMobil
XOM
+$32.7M
4
AAPL icon
Apple
AAPL
+$31.4M
5
HSBC icon
HSBC
HSBC
+$27.6M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.8%
2 Energy 25.94%
3 Financials 12.03%
4 Healthcare 10.86%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
1
Philip Morris
PM
$310B
$1.6B 7.33%
19,008,172
-247,412
-1% -$21.3M
XOM icon
2
ExxonMobil
XOM
$650B
$1.51B 6.93%
15,028,735
-324,622
-2% -$32.7M
KO icon
3
Coca-Cola
KO
$384B
$1.34B 6.14%
31,696,446
-615,790
-2% -$25M
CVX icon
4
Chevron
CVX
$382B
$948M 4.34%
7,259,303
-138,662
-2% -$17.3M
MO icon
5
Altria Group
MO
$125B
$824M 3.77%
19,651,757
-272,089
-1% -$10.9M
AAPL icon
6
Apple
AAPL
$4.98T
$767M 3.51%
32,975,948
-1,474,188
-4% -$31.4M
TROW icon
7
T. Rowe Price
TROW
$25.5B
$676M 3.09%
8,013,135
-1,800
-0% -$147K
EPD icon
8
Enterprise Products Partners
EPD
$83.6B
$645M 2.95%
16,488,470
+127,556
+0.8% +$4.71M
PG icon
9
Procter & Gamble
PG
$339B
$627M 2.87%
7,976,570
-145,452
-2% -$11.7M
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$597M 2.73%
5,703,299
-178,728
-3% -$18.1M
MCD icon
11
McDonald's
MCD
$193B
$452M 2.07%
4,480,726
-134,626
-3% -$13.6M
COP icon
12
ConocoPhillips
COP
$144B
$409M 1.87%
4,767,610
-141,558
-3% -$11M
KMP
13
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$379M 1.74%
4,612,485
-1,700
-0% -$131K
JPM icon
14
JPMorgan Chase
JPM
$918B
$366M 1.68%
6,355,366
-174,526
-3% -$9.81M
PEP icon
15
PepsiCo
PEP
$196B
$345M 1.58%
3,867,117
-102,711
-3% -$8.87M
OXY icon
16
Occidental Petroleum
OXY
$55.7B
$339M 1.55%
3,450,242
-95,220
-3% -$8.95M
MDLZ icon
17
Mondelez International
MDLZ
$83.4B
$334M 1.53%
8,888,437
-193,205
-2% -$7.06M
TTE icon
18
TotalEnergies
TTE
$193B
$328M 1.5%
4,539,011
-156,341
-3% -$10.9M
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
$319M 1.46%
4,307,634
-128,667
-3% -$8.99M
KMI icon
20
Kinder Morgan
KMI
$70.9B
$317M 1.45%
8,730,173
-118,205
-1% -$3.99M
IBM icon
21
IBM
IBM
$213B
$315M 1.44%
1,810,039
-72,495
-4% -$13M
NVO
22
Novo Nordisk
NVO
$228B
$313M 1.43%
13,541,080
-487,942
-3% -$10.8M
ABBV icon
23
AbbVie
ABBV
$466B
$299M 1.37%
5,296,706
-39,709
-0.7% -$2.08M
MRK icon
24
Merck
MRK
$321B
$287M 1.31%
5,198,722
-129,266
-2% -$7.05M
BNY
25
Bank of New York Mellon
BNY
$103B
$277M 1.27%
7,396,599

Similar funds

Fayez Sarofim & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Fayez Sarofim & Co held 276 positions worth $21.9B, up 4.1% from $21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q2 2014 filing shows 31 new, 44 increased, 103 reduced and 5 closed positions. Its largest new stake was AB InBev: 497,729 shares worth $57.2M. The largest sale was Royal Dutch Shell PLC ADS Class A, an estimated $43.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 28% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q2 2014 buy was AB InBev: 497,729 shares worth $57.2M.
  • Fayez Sarofim & Co added most to Twenty-First Century Fox, Inc. Class A in Q2 2014, an estimated $25.7M increase.
  • Fayez Sarofim & Co's biggest Q2 2014 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $43.3M.
  • Fayez Sarofim & Co fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $510K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $21.9B portfolio in Q2 2014.
  • Fayez Sarofim & Co opened 31 new positions and closed 5 in Q2 2014.
  • Fayez Sarofim & Co's portfolio value rose 4.1% quarter-over-quarter to $21.9B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2014, filed 14 Aug 2014.